Edwards Lifesciences (EW) Tops Q2 EPS by 8c; Lifts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Edwards Lifesciences (EW) PT, Estimates Lifted at Piper Jaffray Amid Solid Q2
July 29, 2015 9:02 AM EDTPiper Jaffray analyst Brooks West reiterated an Overweight rating and boosted estimates and his price target on Edwards Lifesciences (NYSE: EW) to $181.00 (from $170.00) following Q2 results.
West commented, "Edwards reported Q2 revenues of $616.8M, beating our Street high estimate of $615.5M and consensus... More
